v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)
Series A
Preferred Stock
Series B
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Beginning balance (in Shares) at Dec. 31, 2024 6,158   16,297,190      
Beginning balance at Dec. 31, 2024 $ 1   $ 1,630 $ 67,683,754 $ (67,703,873) $ (18,488)
Net loss         (3,959,440) (3,959,440)
Payment to shareholder [1]       (10,000)   (10,000)
Shares issued during the period     $ 13 90,621   90,634
Shares issued during the period (in Shares)     125,000      
Stock based compensation       400,297   400,297
Ending balance (in Shares) at Mar. 31, 2025 6,158   16,422,190      
Ending balance at Mar. 31, 2025 $ 1   $ 1,643 68,164,672 (71,663,313) (3,496,997)
Beginning balance (in Shares) at Dec. 31, 2025 1,788   33,193,140      
Beginning balance at Dec. 31, 2025 $ 1   $ 3,319 87,865,771 (82,416,723) 5,452,368
Net loss         (2,600,262) (2,600,262)
Shares issued as part of stock grants to vendors (in Shares)   2,000 3,000,000      
Shares issued as part of stock grants to vendors $ 1   $ 300 1,573,499   1,573,800
Shares issued during the period     $ 267 948,878   949,145
Shares issued during the period (in Shares)     2,665,167      
Shares issued on conversion of preferred stock (in Shares) (1,366)   683,151      
Shares issued on conversion of preferred stock     $ 68 (68)    
Shares issued on exercise of pre-funded warrants     $ 514     514
Shares issued on exercise of pre-funded warrants (in Shares)     5,137,065      
Stock based compensation     $ 262 945,243   $ 945,505
Stock based compensation (in Shares)     2,620,898      
Ending balance (in Shares) at Mar. 31, 2026 422 2,000 47,299,421     1,800,000
Ending balance at Mar. 31, 2026 $ 1   $ 4,730 $ 91,333,323 $ (85,016,985) $ 6,321,070
[1] The payment of $10,000 represents a cash disbursement to an investor under the terms of the June 2024 transaction agreement.